CO5261538A1 - Nuevos acidos (aminopropil) metilfosfinicos - Google Patents
Nuevos acidos (aminopropil) metilfosfinicosInfo
- Publication number
- CO5261538A1 CO5261538A1 CO00093168A CO00093168A CO5261538A1 CO 5261538 A1 CO5261538 A1 CO 5261538A1 CO 00093168 A CO00093168 A CO 00093168A CO 00093168 A CO00093168 A CO 00093168A CO 5261538 A1 CO5261538 A1 CO 5261538A1
- Authority
- CO
- Colombia
- Prior art keywords
- amino
- hydroxypropyl
- acid
- aryl
- hydroxy
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 150000002431 hydrogen Chemical group 0.000 abstract 2
- -1 hydroxy, mercapto Chemical group 0.000 abstract 2
- LRJYUBWOCIHSCA-UHFFFAOYSA-N (3-amino-2-hydroxypropyl)-(difluoromethyl)phosphinic acid Chemical compound NCC(O)CP(O)(=O)C(F)F LRJYUBWOCIHSCA-UHFFFAOYSA-N 0.000 abstract 1
- FUUPFUIGNBPCAY-UHFFFAOYSA-N (3-amino-2-hydroxypropyl)-methylphosphinic acid Chemical compound CP(O)(=O)CC(O)CN FUUPFUIGNBPCAY-UHFFFAOYSA-N 0.000 abstract 1
- CJTIGOOCRLKWAP-UHFFFAOYSA-N (3-amino-2-oxopropyl)-methylphosphinic acid Chemical compound CP(O)(=O)CC(=O)CN CJTIGOOCRLKWAP-UHFFFAOYSA-N 0.000 abstract 1
- XBQLXMFOCPNHDB-BYPYZUCNSA-N CPC[C@H](CN)O Chemical compound CPC[C@H](CN)O XBQLXMFOCPNHDB-BYPYZUCNSA-N 0.000 abstract 1
- FUUPFUIGNBPCAY-SCSAIBSYSA-N [(2r)-3-amino-2-hydroxypropyl]-methylphosphinic acid Chemical compound CP(O)(=O)C[C@H](O)CN FUUPFUIGNBPCAY-SCSAIBSYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 abstract 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000005309 thioalkoxy group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
- C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9904507A SE9904507D0 (sv) | 1999-12-09 | 1999-12-09 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5261538A1 true CO5261538A1 (es) | 2003-03-31 |
Family
ID=20418062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00093168A CO5261538A1 (es) | 1999-12-09 | 2000-12-06 | Nuevos acidos (aminopropil) metilfosfinicos |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6596711B1 (enExample) |
| EP (1) | EP1239843A1 (enExample) |
| JP (1) | JP2003516346A (enExample) |
| KR (1) | KR100752010B1 (enExample) |
| CN (1) | CN1200713C (enExample) |
| AR (1) | AR033350A1 (enExample) |
| AU (1) | AU780259B2 (enExample) |
| BR (1) | BR0016291A (enExample) |
| CA (1) | CA2393510A1 (enExample) |
| CO (1) | CO5261538A1 (enExample) |
| CZ (1) | CZ20021984A3 (enExample) |
| EE (1) | EE200200287A (enExample) |
| HU (1) | HUP0300386A3 (enExample) |
| IL (2) | IL150090A0 (enExample) |
| IS (1) | IS6409A (enExample) |
| MX (1) | MXPA02005537A (enExample) |
| NO (1) | NO20022729L (enExample) |
| NZ (1) | NZ519377A (enExample) |
| PL (1) | PL357115A1 (enExample) |
| RU (1) | RU2267495C2 (enExample) |
| SE (1) | SE9904507D0 (enExample) |
| SK (1) | SK7632002A3 (enExample) |
| TW (1) | TWI225415B (enExample) |
| UA (1) | UA73149C2 (enExample) |
| WO (1) | WO2001041743A1 (enExample) |
| ZA (1) | ZA200204122B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| US7319095B2 (en) * | 1999-12-09 | 2008-01-15 | Astrazeneca Ab | Use of GABAB receptor agonists |
| TW200407110A (en) * | 2001-11-23 | 2004-05-16 | Astrazeneca Ab | New use for the treatment of gastroesophageal reflux disease |
| SE0201939D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination |
| SE0201940D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New combination II |
| DE10305463A1 (de) * | 2003-02-04 | 2004-08-12 | Schering Ag | Enantiomerenreines (4S,8S)- und (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triza-3N,6N,9N-tricarboxymethyl-1,11-undecandisäure und deren Abkömmlinge, Verfahren zu deren Herstellung und Verwendung zur Herstellung pharmazeutischer Mittel |
| SE0401653D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| SE0402462D0 (sv) * | 2004-10-08 | 2004-10-08 | Astrazeneca Ab | New process |
| AU2006327315A1 (en) | 2005-12-23 | 2007-06-28 | Astrazeneca Ab | Imidazole derivatives for the treatment of gastrointestinal disorders |
| AU2006327317B2 (en) | 2005-12-23 | 2010-11-25 | Astrazeneca Ab | GABA-B receptor modulators |
| US8026384B2 (en) | 2007-05-04 | 2011-09-27 | Astrazeneca Ab | Process for the synthesis of alkyl phosphinic acids by initiation of an amine and an amineoxide |
| CN101743011A (zh) * | 2007-07-25 | 2010-06-16 | 阿斯利康(瑞典)有限公司 | (3-氨基-2-氟丙基)次膦酸用于治疗非糜烂性反流病的用途 |
| WO2009082344A1 (en) * | 2007-12-21 | 2009-07-02 | Astrazeneca Ab | Novel process for making (2r)-(3-amino-2-fluoropropyl)phosphinic acid form a |
| EP2235027A4 (en) * | 2007-12-21 | 2011-06-22 | Astrazeneca Ab | NEW CRYSTALLINE FORM OF (2R) - (3-AMINO-2-FLUOROPROPYL) PHOSPHINIC ACID |
| JP2011026260A (ja) * | 2009-07-28 | 2011-02-10 | Central Glass Co Ltd | ３位に脱離基を有する２−フルオロプロピルアミン保護体または該アミンｎ−アルキル保護体 |
| WO2011113904A1 (en) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH449046A (de) | 1963-07-09 | 1967-12-31 | Ciba Geigy | Verfahren zur Herstellung neuer Aminosäuren |
| SU643510A1 (ru) * | 1975-04-11 | 1979-01-25 | Предприятие П/Я А-7815 | Способ получени о-аминофениларилфосфиновых кислот |
| SU589756A1 (ru) * | 1976-01-23 | 1982-10-07 | Институт Органической Химии Ан Усср | Способ получени солей перфторалкилфосфиновых кислот |
| GB8425872D0 (en) | 1984-10-12 | 1984-11-21 | Ciba Geigy Ag | Chemical compounds |
| WO1987004077A1 (en) | 1986-01-03 | 1987-07-16 | The University Of Melbourne | Gastro-oesophageal reflux composition |
| GB8820266D0 (en) | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| US5567840A (en) * | 1989-05-13 | 1996-10-22 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| GB8911017D0 (en) * | 1989-05-13 | 1989-06-28 | Ciba Geigy Ag | Substituted aminoalkylphosphinic acids |
| US5281747A (en) * | 1989-05-13 | 1994-01-25 | Ciba-Geigy Corporation | Substituted aminoalkylphosphinic acids |
| FR2663934B1 (fr) | 1990-06-27 | 1994-06-03 | Adir | Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent. |
| FR2722192A1 (fr) | 1994-07-06 | 1996-01-12 | Adir | Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9420784D0 (en) | 1994-10-14 | 1994-11-30 | Glaxo Group Ltd | Medicaments |
| SE9603408D0 (sv) | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
-
1999
- 1999-12-09 SE SE9904507A patent/SE9904507D0/xx unknown
-
2000
- 2000-04-12 UA UA2002064506A patent/UA73149C2/uk unknown
- 2000-11-27 TW TW089125146A patent/TWI225415B/zh not_active IP Right Cessation
- 2000-12-04 CZ CZ20021984A patent/CZ20021984A3/cs unknown
- 2000-12-04 CA CA002393510A patent/CA2393510A1/en not_active Abandoned
- 2000-12-04 WO PCT/SE2000/002427 patent/WO2001041743A1/en not_active Ceased
- 2000-12-04 MX MXPA02005537A patent/MXPA02005537A/es active IP Right Grant
- 2000-12-04 HU HU0300386A patent/HUP0300386A3/hu unknown
- 2000-12-04 PL PL00357115A patent/PL357115A1/xx not_active IP Right Cessation
- 2000-12-04 EP EP00986117A patent/EP1239843A1/en not_active Withdrawn
- 2000-12-04 NZ NZ519377A patent/NZ519377A/en unknown
- 2000-12-04 EE EEP200200287A patent/EE200200287A/xx unknown
- 2000-12-04 CN CNB008169063A patent/CN1200713C/zh not_active Expired - Fee Related
- 2000-12-04 IL IL15009000A patent/IL150090A0/xx active IP Right Grant
- 2000-12-04 BR BR0016291-4A patent/BR0016291A/pt not_active Application Discontinuation
- 2000-12-04 US US09/786,220 patent/US6596711B1/en not_active Expired - Fee Related
- 2000-12-04 AU AU22412/01A patent/AU780259B2/en not_active Ceased
- 2000-12-04 KR KR1020027007356A patent/KR100752010B1/ko not_active Expired - Fee Related
- 2000-12-04 SK SK763-2002A patent/SK7632002A3/sk not_active Application Discontinuation
- 2000-12-04 RU RU2002113916/04A patent/RU2267495C2/ru not_active Application Discontinuation
- 2000-12-04 JP JP2001543088A patent/JP2003516346A/ja active Pending
- 2000-12-05 AR ARP000106429A patent/AR033350A1/es unknown
- 2000-12-06 CO CO00093168A patent/CO5261538A1/es not_active Application Discontinuation
-
2002
- 2002-05-23 ZA ZA200204122A patent/ZA200204122B/xx unknown
- 2002-06-06 IS IS6409A patent/IS6409A/is unknown
- 2002-06-06 IL IL150090A patent/IL150090A/en not_active IP Right Cessation
- 2002-06-07 NO NO20022729A patent/NO20022729L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2267495C2 (ru) | 2006-01-10 |
| WO2001041743A1 (en) | 2001-06-14 |
| CA2393510A1 (en) | 2001-06-14 |
| CN1200713C (zh) | 2005-05-11 |
| CZ20021984A3 (cs) | 2002-11-13 |
| SE9904507D0 (sv) | 1999-12-09 |
| NO20022729L (no) | 2002-07-09 |
| EP1239843A1 (en) | 2002-09-18 |
| IL150090A (en) | 2006-08-01 |
| PL357115A1 (en) | 2004-07-12 |
| HUP0300386A2 (hu) | 2003-07-28 |
| KR20020060993A (ko) | 2002-07-19 |
| IS6409A (is) | 2002-06-06 |
| IL150090A0 (en) | 2002-12-01 |
| RU2002113916A (ru) | 2004-01-10 |
| AU2241201A (en) | 2001-06-18 |
| ZA200204122B (en) | 2003-10-29 |
| EE200200287A (et) | 2003-08-15 |
| HUP0300386A3 (en) | 2005-08-29 |
| TWI225415B (en) | 2004-12-21 |
| BR0016291A (pt) | 2002-08-13 |
| AU780259B2 (en) | 2005-03-10 |
| KR100752010B1 (ko) | 2007-08-28 |
| US6596711B1 (en) | 2003-07-22 |
| UA73149C2 (en) | 2005-06-15 |
| AR033350A1 (es) | 2003-12-17 |
| JP2003516346A (ja) | 2003-05-13 |
| NO20022729D0 (no) | 2002-06-07 |
| SK7632002A3 (en) | 2003-03-04 |
| MXPA02005537A (es) | 2004-09-10 |
| NZ519377A (en) | 2003-11-28 |
| HK1053066A1 (en) | 2003-10-10 |
| CN1413104A (zh) | 2003-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5180557A1 (es) | Derivados de 1,4-diazabiciclo[3.2.2]nonan-4-carboxilatos y carboxamidas y sus composiciones farmaceuticas . | |
| CO5261589A1 (es) | Compuestos heterociclicos, su produccion y su utilizacion | |
| CO5200785A1 (es) | Uso terapeutico de quinazolina | |
| PT1177176E (pt) | Derivados de acidos triarilicos como ligandos de receptores ppar. | |
| MEP7808A (en) | Process for preparing 4-trifluoromethylsulphinylpyrazole derivative | |
| RU2008132204A (ru) | Соединения для лечения метаболических заболеваний | |
| NO20031490L (no) | Alifatisk nitrogenholdig 5-kantet ring-forbindelse | |
| ES2191412T3 (es) | Derivados de aminoacidos que contienen fluor. | |
| ES2187025T3 (es) | Nuevos agentes quelantes de hierro (iii) activos via oral. | |
| NZ503912A (en) | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists | |
| SE8500877D0 (sv) | Nya enkafalinderivat | |
| TW427979B (en) | A condensed piperidine compound | |
| CO5720995A2 (es) | Compuesto novedoso | |
| HRPK20030233B3 (en) | Process for the preparation of substituted phenylacetonitriles | |
| CO4900047A1 (es) | Amidas del acido 4-(n -benzoilamino)-penten-2-enoico que tienen actividad como antagonistas de neuroquinina | |
| DE60005689D1 (de) | Neue aminobenzophenone | |
| CO5200762A1 (es) | Preparacion de piperidin-4-onas sustituidas | |
| TW355709B (en) | Quinoline carboxylic acid derivative | |
| DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
| DE69706981D1 (de) | Verfahren zur herstellung von pyrimidin-derivaten | |
| AR044175A1 (es) | Compuestos de cefemo | |
| CO5271679A1 (es) | Inhibidores de proteasa 7-14 miembros | |
| CO5150201A1 (es) | Derivados de piperidina | |
| HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
| HRP20010798B1 (hr) | Postupci priprave pesticidnih međuprodukata |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Application granted | ||
| FD | Application lapsed |